Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated Metastatic Breast Cancer

Metastatic Breast ◽

Expanded Access ◽

Expanded Access Program ◽

Microtubules Inhibitors ◽

Lapatinib as salvage therapy in metastatic breast cancer: Preliminary results from an expanded access program

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.12006 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 12006-12006

Author(s):

F. Giotta ◽

A. Latorre ◽

G. Monticelli ◽

S. Oliva ◽

D. Albano ◽

...

Keyword(s):

Breast Cancer ◽

Salvage Therapy ◽

Metastatic Breast ◽

Preliminary Results ◽

Expanded Access ◽

Expanded Access Program ◽

A single-institution experience from the Lapatinib Expanded Access Program – effect of lapatinib and capecitabine combination therapy on CNS metastases in patients with ErbB2+ metastatic breast cancer

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(08)70735-3 ◽

2008 ◽

Vol 6 (7) ◽

pp. 175 ◽

Cited By ~ 1

Author(s):

B. Kaufman ◽

R. Weitzen ◽

A. Goldfarb ◽

N. Ephrat ◽

I. Kuchuk ◽

...

Keyword(s):

Breast Cancer ◽

Combination Therapy ◽

Metastatic Breast ◽

Single Institution ◽

Cns Metastases ◽

Expanded Access ◽

Program Effect ◽

Expanded Access Program ◽

Results of the Belgian expanded access program of eribulin in the treatment of metastatic breast cancer closely mirror those of the pivotal phase III trial

European Journal of Cancer ◽

10.1016/j.ejca.2016.03.010 ◽

2016 ◽

Vol 60 ◽

pp. 117-124 ◽

Cited By ~ 17

Author(s):

Philippe Aftimos ◽

Laura Polastro ◽

Lieveke Ameye ◽

Christiane Jungels ◽

Jalal Vakili ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

Phase Iii ◽

Pivotal Phase ◽

Phase Iii Trial ◽

Expanded Access ◽

Expanded Access Program ◽

Abstract P3-14-15: Lapatinib Plus Capecitabine in Trastuzumab Pre-Treated HER2- Positive Metastatic Breast Cancer: The Canadian Lapatinib Expanded Access Program Experience

10.1158/0008-5472.sabcs10-p3-14-15 ◽

2010 ◽

Author(s):

J Chang ◽

S Chia ◽

C Prady ◽

K Haider ◽

D Grenier ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

Her2 Positive ◽

Expanded Access ◽

Expanded Access Program ◽

124P Talazoparib in locally advanced or metastatic breast cancer patients: Experience from an early access program in Turkey

Annals of Oncology ◽

10.1016/j.annonc.2021.03.138 ◽

2021 ◽

Vol 32 ◽

pp. S74

Author(s):

M.A.N. Sendur ◽

B. Cakar ◽

M. Hızal ◽

E. Eraslan ◽

S. Aksoy ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Locally Advanced ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Early Access ◽

Patients Experience ◽

Efficacy and Safety Data of Taiwan Breast Cancer Patients Enrolled in the Lapatinib Expanded Access Program (LEAP).

10.1158/0008-5472.sabcs-09-5093 ◽

2009 ◽

Author(s):

S. Chen ◽

C. Huang ◽

C. Tsao ◽

M. Liu ◽

D. Yeh ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Safety Data ◽

Efficacy And Safety ◽

Breast Cancer Patients ◽

Expanded Access ◽

Expanded Access Program ◽

Abstract P1-14-04: Clinical Outcomes of Brain Metastasis by Lapatinib (L) and Capecitabine (C) in an Open-Label Expanded Access Study among Korean Patients with HER2 Positive Metastatic Breast Cancer

10.1158/0008-5472.sabcs10-p1-14-04 ◽

2010 ◽

Cited By ~ 1

Author(s):

J Ro ◽

S Park ◽

S-B Kim ◽

T-Y Kim ◽

Y-H Im ◽

...

Keyword(s):

Breast Cancer ◽

Brain Metastasis ◽

Clinical Outcomes ◽

Metastatic Breast ◽

Her2 Positive ◽

Open Label ◽

Expanded Access ◽

Korean Patients

An open-label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancer

Annals of Oncology ◽

10.1093/annonc/mdp373 ◽

2010 ◽

Vol 21 (3) ◽

pp. 474-480 ◽

Cited By ~ 55

Author(s):

G. Capri ◽

J. Chang ◽

S.-C. Chen ◽

P. Conte ◽

K. Cwiertka ◽

...

Keyword(s):

Breast Cancer ◽

Locally Advanced ◽

Metastatic Breast ◽

Open Label ◽

Expanded Access

Fulvestrant in postmenopausal women with metastatic breast cancer progressing on prior endocrine therapy — results from an expanded access programme

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(04)90867-1 ◽

2004 ◽

Vol 2 (3) ◽

pp. 132-133 ◽

Cited By ~ 11

Author(s):

L Petruzelka ◽

M Zimovjanova

Keyword(s):

Breast Cancer ◽

Postmenopausal Women ◽

Endocrine Therapy ◽

Metastatic Breast ◽

Expanded Access ◽

Expanded Access Programme ◽

Access Programme

Treatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme, including efficacy in brain metastases – the UK experience

British Journal of Cancer ◽

10.1038/sj.bjc.6605586 ◽

2010 ◽

Vol 102 (6) ◽

pp. 995-1002 ◽

Cited By ~ 89

Author(s):

S Sutherland ◽

S Ashley ◽

D Miles ◽

S Chan ◽

A Wardley ◽

...

Keyword(s):

Breast Cancer ◽

Brain Metastases ◽

Metastatic Breast ◽

Her2 Positive ◽

Expanded Access ◽

Expanded Access Programme ◽

Access Programme ◽

The Uk